WM
80
6
TRV
42
5
XEL
79
5
BEN
55
-2
HP
36
2
NDAQ
57
2
ETN
55
-2
PLD
58
2
VTR
63
6
CME
59
4
CTAS
27
3
CINF
58
3
PYPL
32
3
AZO
48
-2
MAS
34
-4
KR
49
4
ICE
63
6
ECL
59
-3
COF
47
-3
EQT
65
-3
WM
80
6
TRV
42
5
XEL
79
5
BEN
55
-2
HP
36
2
NDAQ
57
2
ETN
55
-2
PLD
58
2
VTR
63
6
CME
59
4
CTAS
27
3
CINF
58
3
PYPL
32
3
AZO
48
-2
MAS
34
-4
KR
49
4
ICE
63
6
ECL
59
-3
COF
47
-3
EQT
65
-3
Financhill
Back

Currenc Group, Inc. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
72

CURR
Currenc Group, Inc.

Last Price:
$2.88
Seasonality Move:
-3.37%
Buy
100

ORKA
Oruka Therapeutics, Inc.

Last Price:
$53.39
Seasonality Move:
5.42%
Buy
72
Currenc Group, Inc. (CURR) is a Buy

Is Currenc Group, Inc. a Buy, Sell or Hold?

  • The current Currenc Group, Inc. [CURR] share price is $2.87. The Score for CURR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • CURR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
100
Oruka Therapeutics, Inc. (ORKA) is a Buy

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $53.31. The Score for ORKA is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • ORKA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

CURR Stock Price Chart

What is Currenc Group, Inc.'s stock price today?

  • The Currenc Group, Inc. share price today is $2.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CURR is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $53.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing buying pressure, which is a positive indicator for future bullish movement.

CURR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 70.66 Buy
Chaikin Money Flow: 148551 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.23 - 2.59) Buy
Bollinger Bands (100): (1.67 - 2.63) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.1 Buy
Relative Strength Index (14 RSI): 77.59 Buy
Chaikin Money Flow: 1458349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.68 - 45.6) Buy
Bollinger Bands (100): (27.9 - 38.44) Buy

CURR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.57 Buy
20-day SMA: 2.46 Buy
50-day SMA: 2.09 Buy
200-day SMA: 1.91 Buy
8-day EMA: 2.62 Buy
20-day EMA: 2.47 Buy
50-day EMA: 2.24 Buy
200-day EMA: 2.01 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Buy
20-day SMA: 41.09 Buy
50-day SMA: 36.64 Buy
200-day SMA: 25.3 Buy
8-day EMA: 47.34 Buy
20-day EMA: 42.69 Buy
50-day EMA: 37.82 Buy
200-day EMA: 28.4 Buy

Currenc Group, Inc. Earnings Growth & CURR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.31 per share.

Currenc Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):